AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32993325 — intervention group
Group type: COMPARATOR
Intervention: Woodcast splints
Number of subjects: 46
Study 33694345 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness audio recording
Number of subjects: 39
Study 33694345 — intervention group
Group type: COMPARATOR
Intervention: History audio recording
Number of subjects: 39
Study 32945739 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with Ralstonia solanacearum species complex (RSSC) phylotype I strain GMI1000 at a concentration of 10^8 CFU/mL, using soil soak method.
Number of subjects: 0
Study 32945739 — intervention group
Group type: COMPARATOR
Intervention: Water treated plants (negative control).
Number of subjects: 0
Study 35469358 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) intervention for diabetes prevention
Number of subjects: 24
Study 33942563 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally informed treatment based on Intervention Mapping (IM); 4 sessions, each under 1 hour
Number of subjects: 80
Study 33942563 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 35279447 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher initial foster carer commitment
Number of subjects: 144
Study 34784124 — intervention group
Group type: EXPERIMENTAL
Intervention: 1927 nm thulium fiber laser with 0.05% tretinoin lotion
Number of subjects: 0
Study 34784124 — intervention group
Group type: COMPARATOR
Intervention: Vehicle group (no tretinoin lotion)
Number of subjects: 0
Study 32539506 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin or daptomycin with an antistaphylococcal β-lactam
Number of subjects: 0
Study 32539506 — intervention group
Group type: COMPARATOR
Intervention: Usual care (vancomycin or daptomycin without β-lactam)
Number of subjects: 0
Study 36088385 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU liaison nurse services (patient support, family support, training, support of the ward's staff, evaluation of the destination ward)
Number of subjects: 60
Study 36088385 — intervention group
Group type: COMPARATOR
Intervention: Routine transfer care (control group)
Number of subjects: 60
Study 32139254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy diet
Number of subjects: 30
Study 35419116 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-heart nursing combined with seaweed polysaccharide
Number of subjects: 214
Study 35419116 — intervention group
Group type: COMPARATOR
Intervention: Seaweed polysaccharide
Number of subjects: 214
Study 33545764 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (Ensure®) daily in addition to daily routine diets after discharge
Number of subjects: 60
Study 33545764 — intervention group
Group type: COMPARATOR
Intervention: Regular diets after discharge
Number of subjects: 60
Study 32500862 — intervention group
Group type: EXPERIMENTAL
Intervention: D-PLEX500 (biodegradable prolonged release local doxycycline with β-tricalcium phosphate bone graft)
Number of subjects: 27
Study 32500862 — intervention group
Group type: EXPERIMENTAL
Intervention: D-PLEX500
Number of subjects: 27
Study 32500862 — intervention group
Group type: COMPARATOR
Intervention: Control group (no D-PLEX500)
Number of subjects: 27
Study 32500862 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 33860350 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic full-thickness resection (FTR)
Number of subjects: 102
Study 33860350 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic submucosal dissection (ESD)
Number of subjects: 102
Study 33648623 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive hypotension (mean arterial pressure target of 60-65 mmHg)
Number of subjects: 2463
Study 33648623 — intervention group
Group type: COMPARATOR
Intervention: Usual care (mean arterial pressure target at clinician's discretion)
Number of subjects: 2463
Study 33648623 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive hypotension
Number of subjects: 2463
Study 33648623 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2463
Study 32517755 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical function (measured by SPPB) and lean body mass (LBM)
Number of subjects: 81
Study 32517755 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical function (measured by SPPB) and perceived difficulty in walking outdoors
Number of subjects: 81
Study 36477612 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic balloon cryoablation (EBCA) after transurethral resection (TUR)
Number of subjects: 205
Study 36477612 — intervention group
Group type: COMPARATOR
Intervention: Single instillation (SI) of pirarubicin after transurethral resection (TUR)
Number of subjects: 205
Study 33621471 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-dose intramuscular Essen regimen
Number of subjects: 70
Study 33621471 — intervention group
Group type: COMPARATOR
Intervention: 5-dose intramuscular Essen regimen
Number of subjects: 70
Study 32800081 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage (target peak breath alcohol concentration = .08%)
Number of subjects: 297
Study 32800081 — intervention group
Group type: COMPARATOR
Intervention: Control (non-alcoholic beverage)
Number of subjects: 297
Study 35589854 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (anti-CD20 monoclonal antibody)
Number of subjects: 164
Study 35589854 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (anti-IL6R monoclonal antibody)
Number of subjects: 164
Study 35589854 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 164
Study 35589854 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 164
Study 35589854 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug resistance
Number of subjects: 164
Study 34031690 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-source verification conducted on PTA medication list
Number of subjects: 200
Study 35083924 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecularly stratified sub-trial (FOCUS4-B, C, or D)
Number of subjects: 1434
Study 35083924 — intervention group
Group type: EXPERIMENTAL
Intervention: FOCUS4-D (AZD8931 in BRAF-PIK3CA-RAS wildtype subgroup)
Number of subjects: 1434
Study 35083924 — intervention group
Group type: EXPERIMENTAL
Intervention: FOCUS4-B (Aspirin in PIK3CA mutant subgroup)
Number of subjects: 1434
Study 35083924 — intervention group
Group type: EXPERIMENTAL
Intervention: FOCUS4-C (Adavosertib in RAS+TP53 double mutant subgroup)
Number of subjects: 1434
Study 35083924 — intervention group
Group type: COMPARATOR
Intervention: FOCUS4-N (Capecitabine monotherapy)
Number of subjects: 1434
Study 33611239 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application
Number of subjects: 90
Study 33611239 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (written information)
Number of subjects: 90
Study 34626838 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Bevacizumab plus Carboplatin and Paclitaxel (ABCP)
Number of subjects: 1202
Study 34626838 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Carboplatin and Paclitaxel (ACP)
Number of subjects: 1202
Study 34626838 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab plus Carboplatin and Paclitaxel (BCP)
Number of subjects: 1202
Study 34147123 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching strategy to TNFi based on adalimumab serum trough level
Number of subjects: 84
Study 34147123 — intervention group
Group type: COMPARATOR
Intervention: Random allocation to treatment (control group)
Number of subjects: 84
Study 33559864 — intervention group
Group type: EXPERIMENTAL
Intervention: PSV50
Number of subjects: 16
Study 33559864 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA50
Number of subjects: 16
Study 33559864 — intervention group
Group type: COMPARATOR
Intervention: NAVA150
Number of subjects: 16
Study 33559864 — intervention group
Group type: EXPERIMENTAL
Intervention: PSV150
Number of subjects: 16
Study 33931843 — intervention group
Group type: EXPERIMENTAL
Intervention: Neobladder function training based on the action research method
Number of subjects: 68
Study 33931843 — intervention group
Group type: COMPARATOR
Intervention: Neobladder function training
Number of subjects: 68
Study 35792689 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 20
Study 35792689 — intervention group
Group type: COMPARATOR
Intervention: Control (no ESPB)
Number of subjects: 20
Study 34444766 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil cake extract (SOCE) for 12 weeks
Number of subjects: 70
Study 34444766 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 70
Study 33157152 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 55
Study 33157152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 35094258 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative administration of celecoxib
Number of subjects: 106
Study 35094258 — intervention group
Group type: COMPARATOR
Intervention: Postoperative administration of celecoxib
Number of subjects: 106
Study 32456230 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocovid (200 mg twice a day)
Number of subjects: 80
Study 32456230 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice a day)
Number of subjects: 80
Study 35986358 — intervention group
Group type: EXPERIMENTAL
Intervention: Livogen Plus® (nutraceutical) - 6 softgel capsules daily for 12 weeks
Number of subjects: 140
Study 35986358 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin) - 6 softgel capsules daily for 12 weeks
Number of subjects: 140
Study 33174314 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory Resistance Breathing (ERB) with varying stenosis diameters (3 mm, 2 mm, 1.5 mm)
Number of subjects: 14
Study 33174314 — intervention group
Group type: COMPARATOR
Intervention: Metronome-paced tachypnoea (MPT)
Number of subjects: 14
Study 34905434 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural Formulation Interview (CFI+AAU)
Number of subjects: 89
Study 34905434 — intervention group
Group type: COMPARATOR
Intervention: Assessment as Usual (AAU)
Number of subjects: 89
Study 35210384 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 52
Study 35210384 — intervention group
Group type: COMPARATOR
Intervention: Phacotrabeculectomy
Number of subjects: 52
Study 33228827 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme (20 g/head/day)
Number of subjects: 75
Study 33228827 — intervention group
Group type: EXPERIMENTAL
Intervention: Celery (20 g/head/day)
Number of subjects: 75
Study 33228827 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme + Celery (10 g each/head/day)
Number of subjects: 75
Study 33228827 — intervention group
Group type: EXPERIMENTAL
Intervention: Salinomycin (1 g/head/day)
Number of subjects: 75
Study 33228827 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study 35804379 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app for homework assignments
Number of subjects: 35
Study 35804379 — intervention group
Group type: COMPARATOR
Intervention: Paper-and-pencil method for homework assignments
Number of subjects: 35
Study 34929798 — intervention group
Group type: EXPERIMENTAL
Intervention: 5ml ginger oil applied five days before until the second day of the first menstrual period
Number of subjects: 64
Study 34929798 — intervention group
Group type: COMPARATOR
Intervention: 5ml ginger oil applied in the next period
Number of subjects: 64
Study 35614482 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate 100 mg
Number of subjects: 120
Study 35614482 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate 50 mg
Number of subjects: 120
Study 35614482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33947587 — intervention group
Group type: EXPERIMENTAL
Intervention: Care pathway treatment
Number of subjects: 0
Study 33947587 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 36316841 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive therapy of traditional Chinese medicine (CTTCM)
Number of subjects: 108
Study 36316841 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil
Number of subjects: 108
Study 33354954 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Model intervention
Number of subjects: 120
Study 33902646 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive telerehabilitation using a Kinect camera-based system
Number of subjects: 30
Study 33902646 — intervention group
Group type: COMPARATOR
Intervention: Conventional one-on-one physiotherapy
Number of subjects: 30
Study 32556507 — intervention group
Group type: COMPARATOR
Intervention: Non-abuse context vignette
Number of subjects: 172
Study 32556507 — intervention group
Group type: EXPERIMENTAL
Intervention: Abuse context vignette
Number of subjects: 172
Study 34718403 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined weight loss and sodium reduction
Number of subjects: 975
Study 34718403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction alone
Number of subjects: 975
Study 34718403 — intervention group
Group type: COMPARATOR
Intervention: Drug withdrawal (DW)
Number of subjects: 975
Study 34718403 — intervention group
Group type: COMPARATOR
Intervention: Usual care (neither weight loss nor sodium reduction)
Number of subjects: 975
Study 34157349 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CPAP
Number of subjects: 810
Study 34157349 — intervention group
Group type: COMPARATOR
Intervention: Early intubation for surfactant administration
Number of subjects: 810
Study 34157349 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 810
Study 36035830 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA)
Number of subjects: 155
Study 36035830 — intervention group
Group type: COMPARATOR
Intervention: Routine medical consultation (Control)
Number of subjects: 155
Study 32128625 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Patient Education (TPE) with learning objects (LOs) for 60 days
Number of subjects: 0
Study 32128625 — intervention group
Group type: COMPARATOR
Intervention: Usual approach (control group)
Number of subjects: 0
Study 32128625 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Patient Education (TPE) with learning objects (LOs)
Number of subjects: 0
Study 34919025 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education and follow-up
Number of subjects: 64
Study 34919025 — intervention group
Group type: COMPARATOR
Intervention: Control group (no structured education and follow-up)
Number of subjects: 64
Study 34172029 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), delivered in five sessions, in-person
Number of subjects: 10
Study 34172029 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback from participants and hospice staff
Number of subjects: 10
Study 36146092 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (IVR) exergame program for 10 weeks
Number of subjects: 24
Study 36146092 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study 34039193 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized video of surgery
Number of subjects: 97
Study 34039193 — intervention group
Group type: COMPARATOR
Intervention: No video (Control)
Number of subjects: 97
Study 33685232 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured counselling-based intervention (interview at week 0, telephone counselling at weeks 1, 3, and 12)
Number of subjects: 89
Study 33685232 — intervention group
Group type: COMPARATOR
Intervention: General physical activity guidelines for cancer survivors (week 0)
Number of subjects: 89
Study 33685232 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured counselling-based intervention
Number of subjects: 89
Study 33685232 — intervention group
Group type: COMPARATOR
Intervention: General physical activity guidelines for cancer survivors
Number of subjects: 89
Study 32894896 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice evaluators reviewing <30 dual stain slides
Number of subjects: 50
Study 32894896 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice evaluators reviewing 300 dual stain slides
Number of subjects: 50
Study 32894896 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice evaluators reviewing ≥500 dual stain slides
Number of subjects: 50
Study 32894896 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall concordance for all novice evaluators
Number of subjects: 50
Study 36191598 — intervention group
Group type: EXPERIMENTAL
Intervention: Community dialogue approach for disseminating trial results
Number of subjects: 0
Study 36191598 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of local language, pictures, images, and familiar analogies
Number of subjects: 0
Study 36191598 — intervention group
Group type: EXPERIMENTAL
Intervention: Community interpretation of trial results
Number of subjects: 0
Study 33957892 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric average hazard ratio (gAHR)
Number of subjects: 0
Study 33957892 — intervention group
Group type: COMPARATOR
Intervention: Logrank test for composite endpoint (CE)
Number of subjects: 0
Study 34732099 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright blue-green light therapy (experimental group)
Number of subjects: 0
Study 34732099 — intervention group
Group type: COMPARATOR
Intervention: Dim red light therapy (control group)
Number of subjects: 0
Study 34437554 — intervention group
Group type: EXPERIMENTAL
Intervention: 5C scale (Arabic version)
Number of subjects: 350
Study 35180096 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 20
Study 35180096 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation Therapy (MT)
Number of subjects: 20
Study 34092586 — intervention group
Group type: EXPERIMENTAL
Intervention: Apis dorsata Honey (13 ml, 1 tablespoon × 3 for 15 days)
Number of subjects: 30
Study 34092586 — intervention group
Group type: COMPARATOR
Intervention: Control group (no honey)
Number of subjects: 30
Study 36017024 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan combined with MRI diagnostic method
Number of subjects: 236
Study 36017024 — intervention group
Group type: COMPARATOR
Intervention: MRI multiphase dynamic enhancement scan diagnostic method
Number of subjects: 236
Study 32142371 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-linked home BP monitoring
Number of subjects: 826000
Study 32142371 — intervention group
Group type: COMPARATOR
Intervention: Standard home BP monitoring
Number of subjects: 826000
Study 32142371 — intervention group
Group type: EXPERIMENTAL
Intervention: BP control quality improvement program version 1
Number of subjects: 826000
Study 32142371 — intervention group
Group type: COMPARATOR
Intervention: BP control quality improvement program version 2
Number of subjects: 826000
Study 32142371 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall BP control
Number of subjects: 826000
Study 32142371 — intervention group
Group type: EXPERIMENTAL
Intervention: High BP measurement response
Number of subjects: 826000
Study 34718382 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet made entirely from organic foods
Number of subjects: 27
Study 34718382 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet made entirely from conventional foods
Number of subjects: 27
Study 33826449 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation delivered to the common peroneal nerve while walking in addition to standard care
Number of subjects: 64
Study 33826449 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 64
Study 35748642 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvorexant 10 mg
Number of subjects: 14
Study 35748642 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 14
Study 35748642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon 4 mg
Number of subjects: 14
Study 35748642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 34335055 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS treatment
Number of subjects: 119
Study 34335055 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 119
Study 35264321 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavrilimumab 150 mg subcutaneously every 2 weeks with 26-week prednisone taper
Number of subjects: 70
Study 35264321 — intervention group
Group type: COMPARATOR
Intervention: Placebo with 26-week prednisone taper
Number of subjects: 70
Study 32407148 — intervention group
Group type: COMPARATOR
Intervention: DIABEO alone (arm 2)
Number of subjects: 665
Study 32407148 — intervention group
Group type: COMPARATOR
Intervention: DIABEO+telemonitoring (arm 3)
Number of subjects: 665
Study 32337932 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental preparation for dental visits (self-preparation)
Number of subjects: 67
Study 32337932 — intervention group
Group type: COMPARATOR
Intervention: Parental reliance on dentists for preparation
Number of subjects: 67
Study 32337932 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental fear assessment using CFSS-DS
Number of subjects: 67
Study 32337932 — intervention group
Group type: COMPARATOR
Intervention: Comparison of dental fear levels by age and gender
Number of subjects: 67
Study 32337932 — intervention group
Group type: COMPARATOR
Intervention: Association of parent's dental anxiety and pre-appointment preparation with children's dental fear
Number of subjects: 67
Study 35949169 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer-led teaching group (experimental group)
Number of subjects: 217
Study 35949169 — intervention group
Group type: COMPARATOR
Intervention: Teaching as usual group (control)
Number of subjects: 217
Study 36402666 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser acupuncture combined with auricular acupressure (LAA) for 4 weeks
Number of subjects: 76
Study 36402666 — intervention group
Group type: COMPARATOR
Intervention: Sham laser acupuncture treatment (control)
Number of subjects: 76
Study 33990233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy for Suicide Prevention (CTSP) + Treatment as Usual (TAU)
Number of subjects: 150
Study 33990233 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 150